InvestorsHub Logo

GD

Followers 25
Posts 863
Boards Moderated 0
Alias Born 07/12/2002

GD

Re: None

Friday, 11/05/2021 1:00:02 PM

Friday, November 05, 2021 1:00:02 PM

Post# of 462873
FWIW: If the PDD OLE efficacy data is weak, street will really not
like it, even if AVATAR efficacy data is SS, street may assume FDA
want to see 12 months SS data on Rett for approval, IMO. On the other
hand, if PDD OLE data is strong, the efficacy data for CNS drugs that
matters, AVXL will catch up to SAVA MC and pass it with strong Rett
data, IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News